Subcellular localization of truncated MAGEL2 proteins: insight into the molecular pathology of Schaaf-Yang syndrome

Mónica Centeno-Pla,Estefanía Alcaide-Consuegra,Sophie Gibson,Aina Prat-Planas,Juan Diego Gutiérrez-Ávila,Daniel Grinberg,Roser Urreizti,Raquel Rabionet,Susanna Balcells
DOI: https://doi.org/10.1101/2024.01.22.576607
2024-01-23
Abstract:Schaaf-Yang syndrome (SYS) is an ultra-rare neurodevelopmental disorder caused by truncating mutations in . Heterologous expression of wild-type (WT) or a truncated (p.Gln638*) C-terminal HA-tagged MAGEL2 revealed a shift from a primarily cytoplasmic to a more nuclear localization for the truncated protein variant. We now extend this analysis to six additional SYS mutations on a N-terminal FLAG-tagged MAGEL2. Our results replicate and extend our previous findings, showing that all the truncated MAGEL2 proteins consistently display a predominant nuclear localization, irrespective of the C-terminal or N-terminal position and the chemistry of the tag. The variants associated with arthrogryposis multiplex congenita (AMC) display a more pronounced nuclear retention phenotype, suggesting a correlation between clinical severity and the degree of nuclear mis-localization. These results point to a neomorphic effect of truncated MAGEL2, which might contribute to the pathogenesis of SYS.
Molecular Biology
What problem does this paper attempt to address?